Fas-Activated Serine/Threonine Kinase Governs Cardiac Mitochondrial Complex I Functional Integrity in Ischemia/Reperfusion Heart
Open Access
- 28 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Cardiac energy homeostasis is strictly controlled by the mitochondrial complex-mediated respiration. In the heart, mitochondrial complex I is highly susceptible to functional and structural destroy after ischemia/reperfusion (I/R), thereby contributing to myocardial energy insufficiency and cardiomyocyte death. Fas-activated serine/threonine kinase (FASTK) is recently recognized as a key modulator of mitochondrial gene expression and respiration. However, the role of FASTK in cardiac I/R process is undetermined. Here, we show that FASTK expression was down-regulated in the post-I/R heart. The reactive oxygen species scavenger N-acetyl-L-cysteine reversed I/R-induced FASTK down-regulation. Genetic deletion of FASTK exacerbated I/R-induced cardiac dysfunction, enlarged myocardial infarct size, and increased cardiomyocyte apoptosis. Compared with the wild type control, the FASTK deficient heart exhibited a lower mRNA expression of NADH dehydrogenase subunit-6 (MTND6, a mitochondrial gene encoding a subunit of complex I) and was more vulnerable to I/R-associated complex I inactivation. Replenishment of FASTK expression via adenovirus-mediated gene delivery restored mitochondrial complex I activity and ameliorated cardiomyocyte death induced by I/R, whereas these beneficial effects were blocked by the co-treatment with rotenone, a specific complex I inhibitor. in vivo experiments further confirmed that cardiac overexpression of FASTK ameliorated I/R-related MTND6 down-regulation and mitochondrial complex I inactivation, thereby protecting the heart against I/R injury. Collectively, these data for the first time identify that the down-regulation of FASTK is a direct culprit behind the loss of mitochondrial complex I functional integrity and cardiac injury induced by I/R process. Targeting FASTK might be a promising and effective strategy for MI/R intervention.This publication has 25 references indexed in Scilit:
- Brain Ischemia/Reperfusion Injury and Mitochondrial Complex I DamageBiochemistry (Moscow), 2019
- Inhibition of the ubiquitous calpains protects complex I activity and enables improved mitophagy in the heart following ischemia-reperfusionAmerican Journal of Physiology-Cell Physiology, 2019
- The Mitochondrial Isoform of FASTK Modulates Nonopsonic Phagocytosis of Bacteria by Macrophages via Regulation of Respiratory Complex IThe Journal of Immunology, 2018
- Mitochondrial Complex I Dysfunction and Peripheral Chemoreflex Sensitivity in a FASTK-Deficient Mice ModelPublished by Springer Science and Business Media LLC ,2018
- Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstaclesNature Reviews Cardiology, 2018
- Building a complex complex: Assembly of mitochondrial respiratory chain complex ISeminars in Cell & Developmental Biology, 2018
- ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotectionFree Radical Biology & Medicine, 2018
- G protein coupled receptor kinase-2 upregulation causes κ-opioid receptor desensitization in diabetic heartBiochemical and Biophysical Research Communications, 2017
- The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challengeEuropean Heart Journal, 2016
- Myocardial ischemia-reperfusion injury: a neglected therapeutic targetJCI Insight, 2013